An Epigenetic Switch Controls an Alternative NR2F2 Isoform That Unleashes a Metastatic Program in Melanoma

Investigators defined DNA methylation changes that accompany metastatic progression in melanoma patients and discover Nuclear Receptor Subfamily 2 Group F, Member 2 – isoform 2 as an epigenetically regulated metastasis driver.